Delivery Order SPE2DB25D3018-SPE2DB25FUYNC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ivabradine HCL 5 mg tablets (60-count units) with a ceiling value of $19,104.45. This is a firm fixed-price, non-set-aside delivery order that will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.01 to AmerisourceBergen Drug Corp for the supply of Ivabradine HCl 5 mg tablets (60-count package) on September 11, 2025, with an ultimate completion date of September 12, 2025. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is a child...
- The Defense Logistics Agency awarded a $3,992.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ivabradine HCl 5 mg tablets (60-count). This non-set-aside contract is scheduled for completion by August 1, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Ivabradine HCL 5 mg tablets, a pharmaceutical product, with a ceiling value of $12,095.62 and a completion date of June 5, 2025. This delivery order contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
- The Defense Logistics Agency awarded a delivery order valued at $3,730.65 to AmerisourceBergen Drug Corp for Ivabrine HCL 5 mg tablets (60-count) on July 21, 2025, with completion scheduled for July 22, 2025. The contract is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in the same city. This award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $8,002.50 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a 60-count quantity. The contract, awarded September 10, 2025, with completion targeted for September 11, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,188.29 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a quantity of 60 units. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, with a ceiling value of $4,991.17, is for the delivery of ivabradine hydrochloride 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to supply a wide...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Irbesartan 75 mg tablets in a quantity of 90 units, with a ceiling value of $5,990.86. This contract, classified as a firm fixed price delivery order with no set-aside designation, represents a competitively awarded procurement under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ibrance 100 mg tablets in quantities of seven units. This firm fixed price delivery order, valued at $32,489.92, represents a competitive award with no set-aside designation and is scheduled for completion by September 24, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYNCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ivabradine HCL 5 mg tablets (60-count units) with a ceiling value of $3,598.88. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities. The DLA's Medical Supply Chain relies on such prime vendor contracts to efficiently distribute critical medications to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems across multiple regions globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/10/25 |